Global decision makers have been closely working with the world’s top health experts during an extraordinary time and historic moment, to find a solution to the Covid-19 pandemic which has enveloped the globe at the turn of the year 2020.
The UAE’s commitment to global collaboration towards finding solutions to the pandemic and giving hope to humanity is a palpable one; as the United Arab Emirates (UAE) becomes the first country in the region (and the 3rd country in the world) to launch a platform for all UAE citizens and residents to be the first to receive Covid-19 immunisation under safely monitored vaccination trials.
We invite you to make history by being a part of the momentous “Vaccine for Victory (V4V)” campaign, which is the UAE’s chapter of the global vaccination trial of the Sputnik V vaccine, developed by Gamaleya National Research Institute of Epidemiology & Microbiology, in partnership with the Russian Direct Investment Fund (RDIF).
Sputnik V, the human adenovirus vector-based vaccine, was registered by the Russian Ministry of Health on 11th August 2020 and became the first registered COVID-19 vaccine out of 165 vaccines being developed across the world.
With your valuable contribution, and with the expertise of healthcare professionals from Gamaleya National Research Institute of Epidemiology & Microbiology, the UAE’s Ministry of Health and Prevention, and the Abu Dhabi Department of Health, together we will endeavor to embark on a life-saving journey for generations to come.
Our aim is simple: This VACCINE is FOR the world and the V symbolises our mission to claim VICTORY against the pandemic
If you wish to know more about the vaccination trial or the vaccine, please download our brochure by clicking here, or if you want to review our FAQs, please click here.
